Chronic heart failure: evolution of etiology, prevalence and mortality over the past 20 years

Cover Page

Cite item

Full Text

Abstract

The article is devoted to the analysis of changes in the role of causal and comorbid risk factors for two main types of heart failure – with reduced and preserved ejection fraction – over the previous 20 years. Within the same time interval, the dynamics of the prevalence and mortality for these clinical variants. Special attention is paid to a possible solution to the issue of the complexity of recording cases of diagnosis and treatment of chronic heart failure in outpatient and hospital practice.

About the authors

Sergey A. Boytsov

National Medical Research Center of Cardiology; Yevdokimov Moscow State University of Medicine and Dentistry

Author for correspondence.
Email: prof.boytsov@gmail.com
ORCID iD: 0000-0001-6998-8406
SPIN-code: 7961-5520
Scopus Author ID: 56580221300
ResearcherId: M-4486-2014

D. Sci. (Med.), Prof., Acad. RAS, National Medical Research Center of Cardiology

Russian Federation, Moscow; Moscow

References

  1. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Знакомьтесь: диастолическая сердечная недостаточность. Сердечная недостаточность. 2000;1(2):40-4 [Belenkov IuN, Ageev FT, Mareev VIu. Meet diastolic heart failure. Serdechnaia nedostatochnost'. 2000;1(2):40-4 (in Russian)].
  2. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. doi: 10.1161/CIRCHEARTFAILURE.119.006472:e006472
  3. Maddox T, Januzzi JL, Allen LA, et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022
  4. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;8:7-13 [Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Jjournal of Cardiology. 2016;8:7-13 (in Russian)]. doi: 10.15829/1560-4071-2016-8-7-13
  5. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
  6. Buckley BJR, Harrison SL, Fazio-Eynullayeva E, et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679. doi: 10.1111/eci.13679
  7. Lee CCE, Ali K, Connell D, еt al. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9(3):47. doi: 10.3390/diseases9030047
  8. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. MedRxiv. 2021;2021.07.23.21260998 (Preprint). doi: 10.1101/2021.07.23.21260998
  9. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PloS One. 2021;16(7):e0254523. doi: 10.1371/journal.pone.0254523
  10. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. doi: 10.1002/ejhf.1858
  11. Gerber Y, Weston SA, Redfield MM, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. doi: 10.1001/jamainternmed.2015.0924
  12. Поляков Д.С., Фомин И.В., Беленков Ю.Н., и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14 [Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14 (in Russian)]. doi: 10.18087/cardio.2021.4.n1628
  13. Sutcliffe S, Phillips C, Watson D, Davidson C. Trends in heart failure mortality in England and Wales since 1950. Eur J Intern Med. 2007;18(8):576-80. doi: 10.1016/j.ejim.2007.03.014
  14. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14(3):234-9. doi: 10.1093/eurjhf/hfr182
  15. Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732. doi: 10.1038/s41598-020-79926-3
  16. Buddeke J, Valstar GB, Dis I, et al. Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men. BMC Public Health. 2020;20(1):36. doi: 10.1186/s12889-019-7934-3
  17. Available at: https://wonder.cdc.gov/controller/datarequest/D76. Accessed: 16.09.2021.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies